// company-profile

LENZ Therapeutics, Inc.

LENZ
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings64Insiders33
// api This LENZ Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by Thunen Shelley B.

// 90-day insight

Over the last 90 days, LENZ Therapeutics, Inc. insiders bought $366K across 10 transactions with no open-market sales.

  • Most active insider: George Jeffrey P. with 2 transactions totaling $50K.
  • Largest single purchase: $251K by Schimmelpennink Evert B. on Mar 27, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of LENZ Therapeutics, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$293.0M
QoQ change
-42.7%
Reporting period
2026-03-31
#1
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$38.2M
4.2M shares
#2
Alpha Wave Global, LP
CIK 1558858
$33.1M
3.6M shares
#3
Versant Venture Management, LLC
CIK 1560009
$24.3M
2.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 15, 2026Thunen Shelley BLENZ
Award
22,100$0.00$0K
Jun 15, 2026RA CAPITAL MANAGEMENT, L.P.LENZ
Award
22,100$0.00$0K
Jun 15, 2026Drapkin Kimberlee CLENZ
Award
22,100$0.00$0K
Jun 15, 2026MCCOLLUM JAMES WLENZ
Award
22,100$0.00$0K
Jun 15, 2026Guerard FredericLENZ
Award
22,100$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.